Sintx Technologies (SINT) Total Debt Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 300.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300.00% |
| Dec 31, 2025 | -96.63% |
| Sep 30, 2025 | 549.25% |
| Jun 30, 2025 | -54.77% |
| Mar 31, 2025 | -48.07% |
| Dec 31, 2024 | -31.58% |
| Sep 30, 2024 | -80.21% |
| Jun 30, 2024 | -77.35% |
| Mar 31, 2024 | -89.87% |
| Dec 31, 2023 | -94.47% |
| Sep 30, 2023 | 166.54% |
| Jun 30, 2023 | 445.64% |
| Mar 31, 2023 | 851.63% |
| Dec 31, 2022 | 1,683.29% |
| Sep 30, 2022 | -50.10% |
| Jun 30, 2022 | -61.76% |
| Mar 31, 2022 | -159.53% |
| Dec 31, 2021 | -122.75% |
| Sep 30, 2021 | 28.54% |
| Jun 30, 2021 | 21.14% |
| Mar 31, 2021 | -38.52% |
| Dec 31, 2020 | 8,372.22% |
| Sep 30, 2020 | 1,785.71% |
| Jun 30, 2020 | -7.27% |
| Mar 31, 2020 | -23.16% |
| Dec 31, 2019 | -98.31% |
| Sep 30, 2019 | -98.66% |
| Jun 30, 2019 | -92.51% |
| Mar 31, 2019 | -48.07% |
| Dec 31, 2018 | 75.54% |
| Sep 30, 2018 | 51.89% |
| Mar 31, 2018 | -3.85% |
| Dec 31, 2017 | -80.71% |
| Sep 30, 2017 | -82.29% |
| Dec 31, 2016 | -80.83% |
| Sep 30, 2016 | -70.85% |
| Jun 30, 2016 | -50.54% |
| Dec 31, 2015 | -26.05% |
| Sep 30, 2015 | -12.02% |
| Jun 30, 2015 | 45.30% |
| Mar 31, 2015 | 38.03% |
| Dec 31, 2014 | 23.46% |